Pharmacokinetics and Antihypertensive Effects of Candesartan Cilexetil in Patients Undergoing HaemodialysisAn Open-Label, Single-Centre Study

被引：0
|
作者：
Egbert G. Schulz
Shadfar Bahri
Volker Schettler
Aron-Frederik Popov
Matthias Hermann
机构：
[1] Centre of Nephrology Goettingen,Department of Thoracic Cardiovascular Surgery
[2] University of Goettingen,Department of Cardiology
[3] University Hospital Zurich,undefined
来源：
Clinical Drug Investigation | 2009年 / 29卷
关键词：
Candesartan; Aliskiren; Endstage Renal Failure; Candesartan Cilexetil; Anuric Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and Objective: In patients with endstage renal failure (ERF), activation of the renin-angiotensin-aldosterone system plays an important role in the onset and maintenance of arterial hypertension. This study aimed to elucidate the antihypertensive effect, pharmacokinetics and safety of candesartan cilexetil in patients with ERF undergoing haemodialysis.
引用
收藏
页码：713 / 719
页数：6
相关论文
共 50 条
  • [21] Real-world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single-centre, prospective, open-label study
    Gu, C.
    Wu, Y.
    Luo, Y.
    Wang, S.
    Yin, H.
    Gao, Y.
    Wang, C.
    Yao, X.
    Li, W.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : 1064 - 1073
  • [22] Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mgA Randomized, Open-Label, Crossover, Single-Centre Study
    Mona Darwish
    Fang Xie
    Clinical Drug Investigation, 2009, 29 : 145 - 152
  • [23] Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg A Randomized, Open-Label, Crossover, Single-Centre Study
    Darwish, Mona
    Xie, Fang
    CLINICAL DRUG INVESTIGATION, 2009, 29 (03) : 145 - 152
  • [24] Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of MemantineAn Open-Label, Crossover, Single-Centre Study
    Joshua Shua-Haim
    Juanita Smith
    Franck Picard
    Greg Sedek
    Sandeep Athalye
    Françoise Pommier
    Gilbert Lefèvre
    Clinical Drug Investigation, 2008, 28 : 361 - 374
  • [25] Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: An open-label, crossover, single-centre study
    Shua-Haim, Joshua
    Smith, Juanita
    Picard, Franck
    Sedek, Greg
    Athalye, Sandeep
    Pommier, Francoise
    Lefevre, Gilbert
    CLINICAL DRUG INVESTIGATION, 2008, 28 (06) : 361 - 374
  • [26] Treatment with PBI-4050 in patients with Alstrom syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
    Baig, Shanat
    Veeranna, Vishy
    Bolton, Shaun
    Edwards, Nicola
    Tomlinson, Jeremy W.
    Manolopoulos, Konstantinos
    Moran, John
    Steeds, Richard P.
    Geberhiwot, Tarekegn
    BMC ENDOCRINE DISORDERS, 2018, 18
  • [27] Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial
    Bielcikova, Zuzana
    Stursa, Jan
    Krizova, Ludmila
    Dong, Lanfeng
    Spacek, Jan
    Hlousek, Stanislav
    Vocka, Michal
    Rohlenova, Katerina
    Bartosova, Olga
    Cerny, Vladimir
    Padrta, Tomas
    Pesta, Michal
    Michalek, Pavel
    Hubackova, Sona Stemberkova
    Kolostova, Katarina
    Pospisilova, Eliska
    Bobek, Vladimir
    Klezl, Peter
    Zobalova, Renata
    Endaya, Berwini
    Rohlena, Jakub
    Petruzelka, Lubos
    Werner, Lukas
    Neuzil, Jiri
    ECLINICALMEDICINE, 2023, 57
  • [28] Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
    Apolo, Andrea B.
    Nadal, Rosa
    Tomita, Yusuke
    Davarpanah, Nicole N.
    Cordes, Lisa M.
    Steinberg, Seth M.
    Cao, Liang
    Parnes, Howard L.
    Costello, Rene
    Merino, Maria J.
    Folio, Les R.
    Lindenberg, Liza
    Raffeld, Mark
    Lin, Jeffrey
    Lee, Min-Jung
    Lee, Sunmin
    Alarcon, Sylvia V.
    Yuno, Akira
    Dawson, Nancy A.
    Allette, Kimaada
    Roy, Arpita
    De Silva, Dinuka
    Lee, Molly M.
    Sissung, Tristan M.
    Figg, William D.
    Agarwal, Piyush K.
    Wright, John J.
    Ning, Yangmin M.
    Gulley, James L.
    Dahut, William L.
    Bottaro, Donald P.
    Trepel, Jane B.
    LANCET ONCOLOGY, 2020, 21 (08): : 1099 - 1109
  • [29] Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
    Enya, Kazuaki
    Saji, Ben T.
    Kato, Takuya
    Okamoto, Hiroyuki
    Koumura, Emiko
    ADVANCES IN THERAPY, 2018, 35 (08) : 1181 - 1190
  • [30] Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
    Kazuaki Enya
    Ben T. Saji
    Takuya Kato
    Hiroyuki Okamoto
    Emiko Koumura
    Advances in Therapy, 2018, 35 : 1181 - 1190
12345